Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

The osmotic release oral system (OROS) methylphenidate formulation is a prolonged-release medication for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. We conducted a seven-week open-label extension of a double-blind study to assess the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Buitelaar, Jan K, Ramos-Quiroga, J Antoni, Casas, Miguel, Kooij, J J Sandra, Niemelä, Asko, Konofal, Eric, Dejonckheere, Joachim, Challis, Bradford H, Medori, Rossella
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747385/
https://www.ncbi.nlm.nih.gov/pubmed/19777067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747385/
https://www.ncbi.nlm.nih.gov/pubmed/19777067

Ejemplares similares